If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEco Animal Regulatory News (EAH)

Share Price Information for Eco Animal (EAH)

Share Price is delayed by 15 minutes
Get Live Data
91.00    -3.50 (-3.74%)
Bid:
90.00
Ask:
92.00
Spread: 2.00 (2.222%)
Market Cap: £60.38m
EAH Live PriceLast checked at - London Stock Exchange

Intraday Eco Animal Share Chart

Result of EGM

27 Nov 2006 11:56

Kiotech International plc27 November 2006 On behalf of: Kiotech International plc27 November 2006 Results of EGM Kiotech International plc ('Kiotech' or 'the Company') Save as otherwise defined, words and expressions used in this announcement shallhave the meanings set out in the AIM admission document issued by the Companydated 3 November 2006 (the "Admission Document"). Further to the announcement of 3 November 2006, Kiotech, the innovator of fishpheromone technology, announces that all Resolutions relating to the reverseacquisition of Agil, the division of Lawrence plc operating in the animal feedadditive market, were approved by Shareholders at the Company's EGM held today. Application has been made by the Company for the Existing Ordinary Shares,together with the Placing Shares and Consideration Shares, to be admitted totrading on AIM tomorrow morning. Upon Admission, the Acquisition will completeand Richard Edwards will become a Director of the Company assuming the role ofChief Executive. Details of the Acquisition and the appointment of Richard Edwards are includedin the Admission Document, copies of which are available from the offices ofJ.M. Finn & Co. Ltd at Salisbury House, London Wall, London EC2M 5TA. Enquiries: Richard Rose, Chairman Kiotech International Plc07836 250 474 Matthew Robinson/Charles Cunningham, J.M. Finn & Co Ltd0207 628 9688 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
2nd Jul 20267:00 amRNS-REU launch of ECOVAXXIN® MS
4th Jun 20267:00 amRNSRenewal of revolving credit facility
14th Apr 20267:00 amRNSAppointment of Head of Business Development
31st Mar 20267:00 amRNSBoard Change
19th Mar 20267:00 amRNSFull Year Trading Update
11th Mar 20267:00 amRNSECOVAXXIN® MG favourable USDA safety assessment
11th Mar 20267:00 amRNSECOVAXXIN®?MG favourable USDA safety assessment
5th Mar 20264:19 pmRNSBlock Listing Return
26th Feb 20267:00 amRNSEU launch plans for ECOVAXXIN® MS
19th Jan 20261:50 pmRNSHolding(s) in Company
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
22nd Dec 20257:00 amRNSECOVAXXIN® MS EU marketing authorisation granted
18th Dec 20257:00 amRNSExercise of Share Options by Director
9th Dec 20255:57 pmRNSHolding(s) in Company
4th Dec 20252:10 pmRNSDirector/PDMR Shareholding
1st Dec 20257:00 amRNSResults for the six months ended 30 September 2025
20th Nov 20259:47 amRNSReplacement: Notice of Results
20th Nov 20257:00 amRNSNotice of Results
10th Nov 20257:00 amRNSEMA Positive Opinion Received for ECOVAXXIN® MS
1st Oct 20257:00 amRNS-RHead of Global R&D
25th Sep 20253:15 pmRNSResult of AGM
25th Sep 20257:00 amRNSAGM Trading Update and Notice of Interim Results
1st Sep 20257:00 amRNSAppointment of Joint Broker
29th Aug 20257:00 amRNSShare Awards to Executive Directors
28th Aug 20257:48 amRNSPosting of Annual Report and Notice of AGM
21st Aug 202512:29 pmRNSResult of General Meeting
13th Aug 20257:00 amRNSBlock Listing Return
6th Aug 20255:09 pmRNSHolding(s) in Company
17th Jul 20257:00 amRNSHolding(s) in Company
15th Jul 20251:00 pmRNSDirector/PDMR Shareholding
14th Jul 20257:00 amRNSResults for the year ended 31 March 2025
8th Jul 20254:10 pmRNSNotice of General Meeting and Notice of Results
2nd May 20257:00 amRNSHolding(s) in Company
28th Apr 20257:00 amRNSDirector/PDMR Shareholding
24th Apr 20257:00 amRNSTrading Update
13th Mar 20257:00 amRNSR&D Day
3rd Mar 20257:00 amRNSSubmission of Marketing Authorisation Application
24th Feb 20254:08 pmRNSHolding(s) in Company
19th Feb 20257:00 amRNSDisposal of non-core assets
18th Feb 20257:00 amRNSBlock listing Interim Review
13th Feb 20257:00 amRNSNotice of R&D Day
31st Jan 20257:00 amRNSBoard Changes
20th Dec 20247:00 amRNSHolding(s) in Company
16th Dec 20247:00 amRNSHolding(s) in Company
2nd Dec 202412:30 pmRNSShare Purchase by Executive Director
28th Nov 20247:00 amRNSResults for the Six Months Ended 30 September 2024
28th Oct 202412:57 pmRNSShare Awards to Executive Directors
22nd Oct 202411:00 amRNSEBT Share Purchase
21st Oct 20247:00 amRNSEBT Share Purchase
14th Oct 202411:07 amRNSEBT Share Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.